These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12106494)

  • 1. The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases.
    Horwitz DA; Gray JD; Zheng SG
    Arthritis Res; 2002; 4(4):241-6. PubMed ID: 12106494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
    Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
    Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome.
    Zheng SG; Wang JH; Koss MN; Quismorio F; Gray JD; Horwitz DA
    J Immunol; 2004 Feb; 172(3):1531-9. PubMed ID: 14734731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
    Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
    J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.
    Zheng SG; Gray JD; Ohtsuka K; Yamagiwa S; Horwitz DA
    J Immunol; 2002 Oct; 169(8):4183-9. PubMed ID: 12370347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
    Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
    J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus.
    Li X; Kang N; Zhang X; Dong X; Wei W; Cui L; Ba D; He W
    J Immunol; 2011 Jun; 186(12):6693-700. PubMed ID: 21562160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets.
    Horwitz DA; Zheng SG; Gray JD
    J Leukoc Biol; 2003 Oct; 74(4):471-8. PubMed ID: 14519757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets.
    Kang HK; Michaels MA; Berner BR; Datta SK
    J Immunol; 2005 Mar; 174(6):3247-55. PubMed ID: 15749855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta/interleukin-2-induced regulatory CD4+ T cells prolong cardiac allograft survival in rats.
    Watanabe M; Mencel RL; Cramer DV; Starnes VA; Barr ML
    J Heart Lung Transplant; 2005 Dec; 24(12):2153-9. PubMed ID: 16364865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
    Park HB; Paik DJ; Jang E; Hong S; Youn J
    Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells in patients with systemic lupus erythematosus.
    Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R
    J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.
    Sharabi A; Mozes E
    Immunotherapy; 2009 May; 1(3):385-401. PubMed ID: 20635958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient.
    Zheng SG; Meng L; Wang JH; Watanabe M; Barr ML; Cramer DV; Gray JD; Horwitz DA
    Int Immunol; 2006 Feb; 18(2):279-89. PubMed ID: 16415106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15.
    Lee CC; Lin SJ; Cheng PJ; Kuo ML
    Pediatr Allergy Immunol; 2009 Nov; 20(7):624-32. PubMed ID: 19302176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD4CD25 T cells in autoantibody production in murine lupus.
    Hsu WT; Suen JL; Chiang BL
    Clin Exp Immunol; 2006 Sep; 145(3):513-9. PubMed ID: 16907921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.